Department of Pharmacology and Molecular Signaling, College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Department of Physiology and Cellular Biophysics, College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):12051-12056. doi: 10.1073/pnas.1811024115. Epub 2018 Nov 5.
Genetically encoded inhibitors for voltage-dependent Ca (Ca) channels (GECCIs) are useful research tools and potential therapeutics. Rad/Rem/Rem2/Gem (RGK) proteins are Ras-like G proteins that potently inhibit high voltage-activated (HVA) Ca (Ca1/Ca2 family) channels, but their nonselectivity limits their potential applications. We hypothesized that nonselectivity of RGK inhibition derives from their binding to auxiliary Caβ-subunits. To investigate latent Caβ-independent components of inhibition, we coexpressed each RGK individually with Ca1 (Ca1.2/Ca1.3) or Ca2 (Ca2.1/Ca2.2) channels reconstituted in HEK293 cells with either wild-type (WT) β or a mutant version (β) that does not bind RGKs. All four RGKs strongly inhibited Ca1/Ca2 channels reconstituted with WT β By contrast, when channels were reconstituted with β, Rem inhibited only Ca1.2, Rad selectively inhibited Ca1.2 and Ca2.2, while Gem and Rem2 were ineffective. We generated mutant RGKs (Rem[R200A/L227A] and Rad[R208A/L235A]) unable to bind WT Caβ, as confirmed by fluorescence resonance energy transfer. Rem[R200A/L227A] selectively blocked reconstituted Ca1.2 while Rad[R208A/L235A] inhibited Ca1.2/Ca2.2 but not Ca1.3/Ca2.1. Rem[R200A/L227A] and Rad[R208A/L235A] both suppressed endogenous Ca1.2 channels in ventricular cardiomyocytes and selectively blocked 25 and 62%, respectively, of HVA currents in somatosensory neurons of the dorsal root ganglion, corresponding to their distinctive selectivity for Ca1.2 and Ca1.2/Ca2.2 channels. Thus, we have exploited latent β-binding-independent Rem and Rad inhibition of specific Ca1/Ca2 channels to develop selective GECCIs with properties unmatched by current small-molecule Ca channel blockers.
基因编码的电压依赖性钙 (Ca) 通道抑制剂 (GECCIs) 是有用的研究工具和潜在的治疗药物。Rad/Rem/Rem2/Gem (RGK) 蛋白是 Ras 样 G 蛋白,可强烈抑制高电压激活 (HVA) Ca (Ca1/Ca2 家族) 通道,但它们的非选择性限制了它们的潜在应用。我们假设 RGK 抑制的非选择性源于它们与辅助 Caβ-亚基的结合。为了研究抑制作用中潜在的 Caβ-独立成分,我们分别将每个 RGK 与在 HEK293 细胞中重新构成的 Ca1(Ca1.2/Ca1.3)或 Ca2(Ca2.1/Ca2.2)通道与野生型 (WT)β 或不与 RGK 结合的突变体版本 (β) 共表达。所有四种 RGK 均强烈抑制与 WTβ 重新构成的 Ca1/Ca2 通道。相比之下,当通道与β重新构成时,Rem 仅抑制 Ca1.2,Rad 选择性抑制 Ca1.2 和 Ca2.2,而 Gem 和 Rem2 无效。我们生成了不能与 WT Caβ 结合的突变 RGK(Rem[R200A/L227A]和 Rad[R208A/L235A]),正如荧光共振能量转移所证实的那样。Rem[R200A/L227A]选择性阻断重新构成的 Ca1.2,而 Rad[R208A/L235A]抑制 Ca1.2/Ca2.2,但不抑制 Ca1.3/Ca2.1。Rem[R200A/L227A]和 Rad[R208A/L235A]均抑制心室肌细胞中的内源性 Ca1.2 通道,并分别选择性阻断感觉神经元背根神经节中 25%和 62%的 HVA 电流,与它们对 Ca1.2 和 Ca1.2/Ca2.2 通道的独特选择性相对应。因此,我们利用了潜在的β-结合非依赖性 Rem 和 Rad 对特定 Ca1/Ca2 通道的抑制作用,开发了具有当前小分子 Ca 通道阻滞剂所不具备的特性的选择性 GECCIs。